Study S001802

Tolerance and Acceptance of a High Protein Nutrition Shake in Individuals Treated With the GLP-1 Receptor Agonist Semaglutide: a Single Arm, Open Label Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07096739
Study type: INTERVENTIONAL
Masking: NONE
Status: COMPLETED
Enrollment: 20
Start: 2025-08-01
Primary completion: 2025-09-19
Lead sponsor: Kate Farms Inc
Conditions: GLP-1 Concentration
Interventions: DIETARY_SUPPLEMENT:High protein shake
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Composite GI symptoms score (CSS) [7 days]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0005785	Plant-Based Nutrition Alleviates Gastrointestinal Symptoms and Enhances Protein Intake during GLP-1 Therapy. Withrow NA, Current developments in nutrition	2026	Other trial	PMID 42388893 DOI	cites ClinicalTrials.gov:NCT07096739; registry reference DERIVED:42388893